{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:33:33Z","timestamp":1774690413069,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by a hyperinflammatory state due to an aberrant activation of the immune cells. It can be familial or secondary to malignancy, autoimmune or metabolic diseases. Most HLH cases are triggered by infection. Histiocyte society suggested HLH-2004 protocol for diagnosis and treatment of both forms. Here, we present a three-year-old girl with B-cell acute lymphoblastic leukemia who developed HLH secondary to cytomegalovirus infection during maintenance therapy. She was successfully treated without needing full HLH protocol therapy. We discuss modified therapy for this specific group of HLH, summarizing 5 other similar cases in the literature.<\/jats:p>","DOI":"10.1097\/mph.0000000000001547","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T21:44:30Z","timestamp":1562881470000},"page":"313-315","source":"Crossref","is-referenced-by-count":3,"title":["How to Treat Cytomegalovirus-induced Hemophagocytic Lymphohistiocytosis in a Child With Leukemia"],"prefix":"10.1097","volume":"42","author":[{"given":"\u0130rem","family":"Eldem","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad M.","family":"Al-Rahawan","sequence":"additional","affiliation":[{"name":"Pediatrics, Division of Pediatric Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Levent","sequence":"additional","affiliation":[{"name":"Pediatrics, Division of Infectious Disease, Texas Tech University Health Sciences Center, Lubbock, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","article-title":"Hemophagocytic syndrome: primary forms and predisposing conditions","volume":"49","author":"Sepulveda","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/pbc.22064","article-title":"Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis","volume":"53","author":"Devecioglu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1442-200X.2011.03429.x","article-title":"Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia","volume":"54","author":"Kobayashi","year":"2012","journal-title":"Pediatr Int"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MPH.0b013e318279e920","article-title":"Cytomegalovirus retinitis during maintenance therapy for T-cell acute lymphoblastic leukemia","volume":"35","author":"Wakai","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.idcr.2017.07.003","article-title":"Cytomegalovirus induced hemophagocytic lymphocytic histiocytosis in two pediatric patients with acute lymphoblastic leukemia","volume":"9","author":"Waddell","year":"2017","journal-title":"IDCases"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MPH.0000000000000298","article-title":"Cytomegalovirus disease in children with acute lymphoblastic leukemia in the nontransplant setting: case series and review of the literature","volume":"37","author":"Rahbarimanesh","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/102453308X316086","article-title":"Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection","volume":"13","author":"El-Chennawi","year":"2008","journal-title":"Hematology"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5582\/irdr.2016.01018","article-title":"Hemophagocytic lymphohistiocytosis: a rare cause of recurrent encephalopathy","volume":"5","author":"Sulaiman","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"R11-20230918","first-page":"e339","article-title":"Secondary hemophagocytosis in propionic acidemia","volume":"25","author":"Kasapkara","year":"2015","journal-title":"Iran J Pediatr"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/pbc.20255","article-title":"Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group","volume":"44","author":"Ek","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pbc.21287","article-title":"Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients","volume":"50","author":"Kim","year":"2008","journal-title":"Pediatric Blood Cancer"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:41:03Z","timestamp":1695012063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001547","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}